New Math Data Signs Strategic Collaboration Agreement with AWS to Deliver Production AI and Data Solutions

HOUSTON, Sept. 2, 2026 /PRNewswire/ -- New Math Data, the 2025 AWS Rising Star Partner of the Year for North America, announced today that it has signed a multi-year strategic collaboration agreement (SCA) with Amazon Web Services (AWS) to accelerate enterprise AI adoption, helping businesses solve their most challenging problems with AI solutions featuring built-in governance, guardrails, and cost-effective architecture.

As AI becomes increasingly capable of addressing sophisticated enterprise business problems, many companies struggle to move beyond promising pilots to secure, scalable production deployments that deliver measurable business value. New Math Data helps customers bridge that gap through proven delivery methodologies, deep technical expertise, and AWS-recognized Competencies in Generative AI, Agentic AI, DevOps, and Data and Analytics. The SCA expands New Math Data's AI capabilities through deeper investment in production-ready agentic solutions, frameworks, and additional offerings available through AWS Marketplace, as well as enhanced post-deployment services, helping organizations accelerate time to value while reducing implementation risk.

"Customer obsession means moving beyond shiny demos to delivering outcomes that change the course of business," said Bernard Hatch, CEO of New Math Data. "This agreement gives us a new set of tools to help our clients achieve the outcomes that agentic AI promises. AWS brings depth and the reach. We bring expertise, multipliers, and hard-won lessons from hundreds of live deployments to deliver a faster, lower-risk path to working agents that demonstrate strong ROI."

"We've all seen AI demos that never survive contact with real customers. Ours did," said Qi Sun, CTO of Gori Company. "New Math Data took our AI assistant to production and built the foundation we're now extending into predictive delivery and carrier recommendations. They move at our speed."

"Customers in regulated industries need AI solutions they can deploy with confidence, control, and speed to production," said Melissa Dougherty, Director – AMER Consulting Partners at AWS. "New Math Data brings our newest agentic AI services into customer environments early, proving what production-ready looks like before it becomes table stakes. This collaboration gives more customers a faster path from concept to measurable outcomes."

The agreement deepens a collaboration that has produced hundreds of customer wins, many in novel AI use cases. For more information, visit New Math Data: https://www.newmathdata.com

About New Math Data

New Math Data is an AWS Advanced Tier Services Partner and the 2025 AWS Rising Star Partner of the Year for North America, headquartered in Houston, Texas. The firm designs and operates cloud, data, and AI systems for customers in financial services, energy and utilities, healthcare, and other sectors. New Math Data holds the AWS Competency certifications in Generative AI (with Agentic Specialization), Data and Analytics, and DevOps. The firm specializes in taking complex AI and data use cases from inception to production. Learn more at www.newmathdata.com.

Media Contact: Jeffery McLaughlin, jmclaughlin@newmathdata.com

SOURCE New Math Data LLC

Share this article

HUAWEI WATCH D3 fa il suo debutto anticipato al Congresso ESC 2026: Una nuova era nella gestione della pressione sanguigna basata sul polso

MONACO DI BAVIERA, 2 settembre 2026 /PRNewswire/ -- La European Society of Cardiology Congress (ESC Congress 2026), uno degli incontri accademici più influenti al mondo in medicina cardiovascolare, è ufficialmente iniziata oggi a Monaco di Baviera, in Germania. Huawei ha presentato le sue ultime innovazioni nel campo della salute e del fitness, offrendo un'esclusiva panoramica del monitor ambulatoriale della pressione sanguigna di nuova generazione, il HUAWEI WATCH D3, in vista del suo lancio ufficiale al Huawei Innovative Product Launch a Monaco di Baviera il 2 settembre. Collegando la ricerca accademica all'avanguardia con la tecnologia di consumo di tutti i giorni, Huawei continua a dimostrare il suo impegno per una collaborazione aperta, collegando la ricerca pionieristica con prodotti che rimodellano la vita quotidiana delle persone.

Un retaggio di perseveranza, un salto in avanti

Il viaggio di Huawei nella tecnologia di monitoraggio della pressione sanguigna risale al 2014, quando la società si è avventurata per la prima volta nel campo dello sport e della salute. Nel corso dell'ultimo decennio, Huawei ha costantemente avanzato le tecnologie di monitoraggio della salute indossabili per guidare l'evoluzione del settore, dal monitoraggio dinamico della frequenza cardiaca e dal tracciamento dello SpO2 alla raccolta dell'ECG e, infine, alla misurazione della pressione sanguigna.

Nel 2021, Huawei ha lanciato il suo primo registratore di pressione sanguigna ambulatoriale basato sul polso, il HUAWEI WATCH D. Questo dispositivo ha portato per la prima volta capacità di misurazione della pressione sanguigna di livello medico ai polsi delle persone, garantendo la certificazione dei dispositivi medici in più paesi e regioni, compresa la Cina e l'Unione europea. Nel 2024, il HUAWEI WATCH D2 è stato ufficialmente rilasciato, introducendo il monitoraggio ambulatoriale della pressione sanguigna 24 ore su 24 e ridefinendo la gestione della pressione sanguigna.

Nel 2026, Huawei presenterà il suo ultimo risultato nella salute della pressione sanguigna, la serie HUAWEI WATCH D di nuova generazione. Come l'ultimo registratore di pressione sanguigna ambulatoriale basato sul polso, HUAWEI WATCH D3 ottiene ulteriori innovazioni in più scenari di misurazione della pressione sanguigna fornendo al contempo una protezione della salute più completa.

Design leggero, professionalità e stile

Per migliorare il comfort durante l'uso prolungato, HUAWEI WATCH D3 presenta ulteriori miglioramenti nello spessore del dispositivo e nel peso del cinturino. Sarà disponibile in tre opzioni di colori alla moda ispirate alla "guarigione della natura", progettate non solo per il comfort, ma anche come accessorio di uso quotidiano elegante, che si fonde perfettamente con diversi stili di vita e scenari sportivi.

Scenari più ampi, informazioni più approfondite sulla salute

HUAWEI WATCH D3 garantisce una misurazione accurata della pressione sanguigna a frequenze cardiache elevate. Registra accuratamente i dati sulla pressione sanguigna prima e dopo l'esercizio fisico, fornisce raccomandazioni sull'intensità dell'esercizio appropriata e aiuta gli utenti a sviluppare buone abitudini di fitness. Inoltre, HUAWEI WATCH D3 è stato certificato CE MDR nell'Unione europea, il cui ambito di certificazione comprende misurazioni singole della pressione sanguigna, monitoraggio ambulatoriale della pressione sanguigna e misurazioni della pressione sanguigna prima e dopo l'esercizio fisico. Le nuove funzionalità includono promemoria di misurazione della pressione sanguigna per ambienti ad alta quota e cambiamenti improvvisi di temperatura, garantendo agli utenti di non perdere mai un controllo di monitoraggio critico.

Oltre alle sue principali capacità di monitoraggio della pressione sanguigna, HUAWEI WATCH D3 offre anche metriche e studi sulla salute Health Glance più ricchi, oltre a continui miglioramenti nel sonno e nel monitoraggio del benessere emotivo[1]. Ulteriori dettagli sulle domande specifiche saranno annunciati a tempo debito.

Restate sintonizzati sui canali ufficiali di Huawei per informazioni sulla data di lancio ufficiale, sui prezzi e sulle specifiche complete di HUAWEI WATCH D3.

Share this article

Klingbeil hat mit der Einkommensteuerreform eine Chance verpasst

Straubing (ots)

Dass im Konzept Klingbeils kein Ausgleich der sogenannten kalten Progression vorgesehen ist, birgt für die Betroffenen besonders hohes Frustrationspotenzial. Wer durch eine Gehaltserhöhung in einen höheren Steuertarif rutscht und dann auch noch die Inflation zu spüren bekommt, der kann sich am Ende kaum mehr leisten.Längst wird die SPD nicht mehr als die Anwältin der leistungsbereiten, arbeitenden Mitte der Gesellschaft wahrgenommen, sondern eher als Vertreterin derer, die Leistungen beziehen. Die Steuerreform hätte die Gelegenheit geboten, diesen Eindruck zu widerlegen.

Pressekontakt:

Straubinger Tagblatt

Ressort Politik/Wirtschaft/Vermischtes

Markus Peherstorfer

Telefon: 09421-940 4441

politik@straubinger-tagblatt.de

Original-Content von: Straubinger Tagblatt, übermittelt durch news aktuell

Boeing CEO Kelly Ortberg to Speak at Morgan Stanley Laguna Conference September 16

ARLINGTON, Va., Sept. 2, 2026 /PRNewswire/ -- Boeing [NYSE: BA] President and Chief Executive Officer Kelly Ortberg will speak at the Morgan Stanley Laguna Conference on September 16 at 11:30 a.m. PT.

The event webcast, as well as a subsequent transcript, can be accessed on the Events and Presentations section of www.boeing.com/investors. Participants are encouraged to verify access to the webcast prior to the start of the event.

Contact

Investor Relations

BoeingInvestorRelations@boeing.com

Boeing Media Relations

media@boeing.com

SOURCE Boeing

Share this article

From networking and empowerment to celebration and fundraising, GGW invites industry to partake in dynamic, mission-driven programming

LAS VEGAS, Sept. 2, 2026 /PRNewswire/ -- Global Gaming Women (GGW), a non-profit dedicated to supporting, inspiring, and influencing the development of women in gaming, today announced its event lineup for the 2026 Global Gaming Expo in Las Vegas. Celebrating its 10-year anniversary in 2026, GGW will host a variety of events focused on networking, education, celebration, and fundraising – all with the shared goal of uplifting women in the global gaming sector.

"Global Gaming Women is proud to present a robust calendar of events that bring our mission and impact to life through dynamic programming at the 2026 Global Gaming Expo," said Siobhan Lane, GGW president and board chair. "As we celebrate our 10-year anniversary and achieving the 10,000 global member milestone, we are motivated to deliver engaging programming that resonates with our diverse member base, deepens industry connections, and accelerates the professional development of women across the industry."

GGW 2026 G2E programming will include:

Day Zero Party: Sunday, Sept. 27

Hosted in partnership with CDC Gaming, this invite-only event at Resorts World Las Vegas celebrates the 2026 class of 10 Women Rising in Gaming and sets the tone for the inspiring and productive week ahead.

Link and L.E.A.R.N.: Tuesday, Sept. 29 | 6:00 PM – 8:00 PM

For the first time at G2E, GGW will host one of its signature Link and L.E.A.R.N. events. Join GGW in Delfino Room 4001 at The Venetian Expo for inspiring programming, connection and light bites in a social setting. This is a free event; pre-registering via this link is recommended.

GGW Retreat: Tuesday, Sept. 29 - Thursday, Oct. 1

Located in Delfino Room 4001 of The Venetian Expo, the GGW Retreat is the perfect place to foster connection, recharge and gain deeper insight into all that GGW has to offer. The GGW Retreat can be enjoyed during the following hours:

- Tuesday, Sept. 29: 9:00 AM – 5:00 PM

- Wednesday, Sept. 30: 9:00 AM – 5:00 PM

- Thursday, Oct. 1: 9:00 AM – 1:00 PM

American Gaming Association's Gaming Hall of Fame: Tuesday, Sept. 29 | 5:00 PM

GGW leaders will join the American Gaming Association (AGA) in honoring GGW Founder's Circle and Advisory Board member Holly Gagnon as she is inducted into the AGA Gaming Hall of Fame at this invite-only event. Gagnon will be celebrated for her outstanding contributions to the gaming industry and continued commitment to elevating women in gaming.

Sip & Social: Wednesday, Sept. 30 | 8:00 AM – 10:00 AM

An annual GGW event, Sip & Social melds roundtable networking with an inspiring keynote speaker held on G2E's Main Stage. Sip & Social is a complimentary and ticketed event that will take place at Venetian Ballroom B/C/D. This year's Main Stage Feature, presented in partnership with RX and the American Gaming Association, will feature abduction survivor and motivational speaker Elizabeth Smart. In the moderated conversation, she will share her perspective on resilience and reclaiming authorship of personal stories beyond labels in life and at work.

To secure tickets for Sip & Social, please click here.

Kick Up Your Heels Fundraiser: Wednesday, Sept. 30 | 5:00 PM - 7:00 PM

With a new host venue, Intrigue at Wynn Las Vegas, and made possible by contributions from generous sponsors, Kick Up Your Heels is GGW's flagship fundraising event. Presented in a luxury setting, Kick Up Your Heels attracts leaders from across the sector and is the ideal environment for networking and connection. The 2026 Patty Becker Pay It Forward award winners are honored at this ticketed event. Tickets are available for purchase here.

G2E Panel Participation

GGW has helped assemble compelling panel discussions open to anyone holding a G2E Education Conference pass. Must-see GGW panels include:

- Leadership Without Burnout: How High Performers Protect Their Energy

- Wednesday, Sept. 30 I 3:10 – 4:00 PM

- Negotiating Your Value: Money, Influence, and Career Advancement

- Wednesday, Sept. 30 I 11:40 AM – 12:30 PM

For a full view of GGW's G2E programming, visit globalgamingwomen.org. For more information about Global Gaming Women, follow us on LinkedIn and Instagram or visit globalgamingwomen.org.

About Global Gaming Women

Global Gaming Women (GGW) supports, inspires, and influences the development of women in the gaming industry. GGW brings together women from all gaming segments to enrich their professional and personal lives. Established by the American Gaming Association to create a broad network that allows peers to connect with their colleagues, GGW's goal is for female gaming professionals to learn from one another, create lasting connections, and nurture emerging women leaders.

Media Contact

Pamela Buckley

Executive Vice President, Global Gaming Women

+1 (702) 480-5075

info@globalgamingwomen.org

SOURCE Global Gaming Women (GGW)

Share this article

The vehicle is one of the most valuable assets most Americans own. Now it has a home inside the app where they manage the rest of their money.

NEW YORK, Sept. 2, 2026 /PRNewswire/ -- For many Americans, the vehicle in the driveway is one of their most valuable assets and, between loan or lease payments, insurance, and gas, also one of their biggest monthly expenses. Yet its full financial picture — what it's worth, what's owed, loan payoff timeline, insurance information — has always been scattered and incomplete, leaving most owners without the data they need to make smarter decisions.

Today, OnePay, the consumer fintech trusted by millions of Americans to make money better, announced the launch of My Garage. Consumers can have access to an up to date vehicle value, loan equity, payoff timeline, auto insurance offers, and gas rewards, all in one place inside the app where they manage the rest of their financial lives.

Instead of hunting across multiple apps for a partial picture, consumers can have one clear financial view into their vehicle. They can watch their payoff timeline shorten as they move toward owning their vehicle outright, and soon will be able to compare auto loan refinance rates. Further, they can compare insurance offers, access gas rewards and more, all without leaving the app.

"Consumers don't think in terms of financial products. They think about what those products make possible in their lives. And for millions of Americans, owning a car unlocks opportunities. My Garage is about giving people financial visibility into one of the most expensive assets they own but rarely fully understand," said Pat McLoughlin, GM of Marketplace at OnePay.

My Garage begins rolling out to OnePay customers today.

About OnePay

OnePay is an all-in-one financial services platform built on the simple belief that better money makes life better. With banking, high-yield savings, credit cards, point-of-sale lending, investment and crypto offerings, OnePay is providing millions of consumers with the tools they need to holistically manage their financial lives in one place. Alongside its expanding consumer offering, OnePay also partners with employers, HCM providers, gig platforms, and others to deliver embedded financial services to millions of employees and frontline workers.

OnePay is a financial technology company, not a bank. Banking services through OnePay are provided by Coastal Community Bank or Lead Bank, Members FDIC. OnePay debit and credit cards (including the Builder Mastercard®) are issued by partner banks pursuant to licensing by Mastercard® International. Brokerage services through OnePay are provided by One Growth Securities LLC, member FINRA/SIPC. Crypto services through OnePay powered by Zero Hash LLC and Zero Hash Liquidity Services LLC through an agreement with OneProgress Assets LLC. Investment and crypto products are not FDIC Insured, not bank guaranteed and may lose value. One Growth Securities LLC does not provide crypto services and OneProgress Assets LLC is not a member of FINRA/SIPC.

Media contact

press@onepay.com

SOURCE OnePay

Share this article

AMHERST, Mass., Sept. 2, 2026 /PRNewswire/ -- UMass Athletics and Baystate Health, in collaboration with Learfield's UMass Sports Properties, announced today an expanded, multi-year partnership that will bring new on-field branding and additional fan engagement opportunities to UMass Athletics.

The expanded partnership brings together two of the region's largest employers and well-known organizations – UMass Amherst and Baystate Health – who already have a strong academic and clinical relationship and are deeply connected in the community. Each semester, Baystate Health hosts UMass undergraduate students for clinical placements across its hospitals, offering preceptorships for many seniors, and clinical hours for graduate students pursuing advanced degrees. Baystate Nursing Research collaborates with the Elaine Marieb Center for Nursing and Engineering Innovation to support nurse-led research and innovation. This fall, Baystate and UMass Amherst launched an internship program for students interested in careers in business-related fields, including marketing and finance. Together, UMass Amherst and Baystate Health are investing in thousands of employees, students, patients, families, and fans across the region, to strengthen community connections, invest in the region and help generations thrive.

"UMass Amherst and Baystate Health have done much together over the decades, and this is a unique opportunity to further strengthen a longstanding partnership," said Peter D. Banko, President & CEO of Baystate Health. "We are excited to deepen our support of UMass, its athletic programs, and its student athletes and hope this can be the impetus for other organizations to join us in advancing communities across Western Massachusetts."

Beginning with the 2026 football season, the Baystate Health logo will be featured on both 25-yard lines at McGuirk Alumni Stadium, the home of Minuteman football since 1965. The new placement marks the first time a brand's logo will be featured on the gridiron and a significant expansion of the health system's longstanding partnership with UMass Athletics.

"Baystate Health has been an outstanding partner of Massachusetts Athletics for more than a decade, and we're excited to keep growing that partnership for years to come," said Director of Athletics Ryan Bamford. "Baystate Health's commitment reflects a shared investment in the health, well-being and success of our more than 650 student-athletes and the broader UMass community. We're grateful for the continued support and look forward to achieving even more together."

Baystate Health will also have a presence across UMass hockey and men's and women's basketball with prominent branding throughout the Mullins Center, including the 'Baystate Benches' featuring exclusive signage behind both hockey benches. The partnership also expands the Junior Captain of the Game, a fan-favorite UMass Hockey promotion, to include every home football and hockey game throughout the 2026-27 season. The program gives local aspiring young athletes and dedicated fans (ages 6 to 12 years) the opportunity to be recognized as Junior Captain and join the team for a memorable gameday experience, alongside in-game recognition and social media enter-to-win sweepstakes opportunities for UMass fans.

With a workforce of nearly 13,000 team members, Baystate Health is an economic and health pillar in Western Massachusetts serving over 800,000 people. The partnership connects the integrated health system with a passionate UMass fan base in the region. According to Learfield's Fanbase platform, the largest proprietary fan data database in college athletics, more than 325,000 UMass fans live within 10 miles of a Baystate Health location, while nearly half of all UMass fans visited Baystate Medical Center in the past 12 months.

"Baystate Health and UMass Athletics have deep roots in Western Massachusetts, making this a natural partnership with tremendous potential to connect with the local community," said Andrew Stuebner, General Manager of UMass Sports Properties. "We are proud to help build partnerships that are not only highly visible but strategically aligned with the communities and audiences our partners want to reach."

UMass Sports Properties, the locally based team of Learfield – the leading media and technology company powering college sports – is the exclusive multimedia rights holder for UMass Athletics and handles all sponsorships, in-venue signage, and advertising on behalf of the university.

About UMass Athletics

Massachusetts Athletics is home to 21 NCAA Division I programs and more than 650 student-athletes. who proudly represent the Commonwealth. Guided by its mission to Educate, Win, Inspire and Invest, the department is committed to developing champions in competition, the classroom and the community through strategic investments in people, programs and facilities. That commitment is reflected in our student-athletes' sustained academic excellence, highlighted by a school-record NCAA Academic Progress Rate (APR) score of 995 for the 2024-25 academic year and 20 consecutive semesters with a departmental GPA above 3.0. As a proud member of the Mid-American Conference, Hockey East, the Atlantic 10 (men's lacrosse), the Summit League (men's soccer) and the Missouri Valley Conference (men's swimming and diving), Massachusetts Athletics continues to elevate its programs while building meaningful connections with alumni, fans, corporate partners and communities throughout New England and beyond.

About Baystate Healthcare

Baystate Health is a not-for-profit, integrated healthcare system with hospitals, physician practices, a health plan and more serving over 800,000 people throughout western New England. Baystate Health is the safety net provider in Western Massachusetts. With roots dating to the founding of Springfield Hospital in 1883, Baystate Health has been providing high-quality, compassionate and accessible care in the Pioneer Valley for more than 140 years and continues to be a pillar of its community – rooted here, serving here, and helping generations thrive here. With a focus on advancing health for all, Baystate is not only a keystone of the region, it is a national leader in healthcare. Learn more at BaystateHealth.org.

About Learfield

Learfield is the leading media and technology company powering college athletics. Through its digital and physical platforms, Learfield owns and leverages a deep data set and relationships in the industry to drive revenue, growth, brand awareness, and fan engagement for brands, sports, and entertainment properties. With ties to over 1,200 collegiate institutions and over 12,000 local and national brand partners, Learfield's presence in college sports and live events delivers influence and maximizes reach to target audiences. With solutions for a 365-day, 24/7 fan experience, Learfield enables schools and brands to connect with fans through licensed merchandise, game ticketing, donor identification for athletic programs, exclusive custom content, innovative marketing initiatives, NIL solutions, and advanced digital platforms. Since 2008, it has served as title sponsor for the acclaimed Learfield Directors' Cup, supporting athletic departments across all divisions.

SOURCE Baystate Health System

Share this article

- Morgan Health, CVS Health Ventures, and Humana, alongside other strategic payers and providers, invest in Thyme Care at a valuation of more than $2B

- The new capital accelerates Thyme Care's continued growth and establishes Thyme Companies, a newly formed parent entity building a broader portfolio of businesses to tackle distinct parts of the oncology journey

NASHVILLE, Tenn., Sept. 2, 2026 /PRNewswire/ -- Thyme Care, the nationally recognized oncology company, today announced a new Series E financing round of over $125M. Morgan Health led the round, with participation from strategic healthcare investors Humana and CVS Health Ventures, as well as institutional investors AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health.

The financing brings together strategic investors from across the cancer care ecosystem, including the largest national payers, community oncology, health systems, and leaders in employer-sponsored health care, reflecting favorable investor outlook on Thyme Care's care model and its potential to take on the broader challenges in cancer care. Today, Thyme Care services are available to more than 10.5 million people across all 50 states, and the company manages more than $7 billion in oncology spend. By aligning care around the patient, the model delivers 5 to 10 percent validated reductions in total cost of care, creating measurable value for patients, providers, and health plan partners. Supported by strong financial discipline, Thyme Care is profitable, generates meaningful positive free cash flow, and is positioned to accelerate its next phase of growth.

"People living with cancer have traditionally been left to coordinate care themselves and pay more along the way. Thyme Care is changing that experience and making it possible to improve cancer care while lowering costs," said Dan Mendelson, chief executive officer of Morgan Health. "We're continuing to invest in Thyme Care because we're confident they can continue to deliver value to patients and payers – as they make the next wave of cancer care innovation easier to access and navigate."

Alongside the Series E, Thyme Care is establishing Thyme Companies, a newly formed parent entity designed to build a portfolio of new, independent businesses in oncology that address persistent barriers to better cancer care. Grounded in data, enabled by technology, and built on trusted partnerships, Thyme Companies is positioned to take on oncology's biggest challenges. Areas under active development include accelerating the adoption of lower-cost biosimilars and improving clinical trial accrual, where slow enrollment limits patient access to beneficial trials and slows drug development. The first of these businesses is expected to launch later this year.

To support this next phase of growth, Thyme Care co-founder Robin Shah will serve as executive chairman of Thyme Companies leading the strategy and development of new businesses and working closely with his co-founder Bobby Green, M.D. to bring the connected, patient-first approach that built Thyme Care, to a broader set of healthcare challenges. Thyme Care continues under CEO Brad Diephuis, M.D., with Dr. Green as president and chief medical officer. Thyme Care remains the anchor of the Thyme Companies family of businesses; its name, partnerships, and member experience unchanged.

"When we founded Thyme Care, our vision was never limited to one part of cancer care. We wanted to create a better oncology care system," says Shah. "Thyme Care showed it could be done, and as we've grown alongside patients, providers and health plans, we've gained a deep perspective on the challenges that get in the way of better care. Thyme Companies is the next step in this journey, enabling us to build new solutions fully informed by what we've learned, while continuing to invest in the core business that made it possible."

About Thyme Companies

Thyme Companies is the parent of the Thyme family of businesses, focused on building companies against the disconnection in how cancer care is delivered, accessed and paid for. Anchored by Thyme Care, the nationally recognized oncology care company, Thyme Companies develops independent businesses connected by one mission: to transform the experience of cancer for the people living through it. To learn more, visit thymecompanies.com.

About Thyme Care

Thyme Care aligns accountability across the cancer care journey, coordinating patients, providers, and health plans around a shared model of care that drives better outcomes and lower costs for everyone. Through dedicated care teams and technology, Thyme Care integrates directly into existing workflows to support patients longitudinally, close gaps between visits, and align clinical decisions with financial accountability. To learn more, visit thymecare.com.

Inkhouse for Thyme Care

thymecare@inkhouse.com

SOURCE Thyme Care

Share this article

NEW YORK, Sept. 2, 2026 /PRNewswire/ -- Deloitte has been recognized as a Leader in the IDC MarketScape: Worldwide Managed Detection Response/Managed Extended Detection and Response for the Enterprise 2026 Vendor Assessment (doc # US54792426, August 2026). Deloitte is one of seven vendors included in the Leaders Category among the 20 vendors evaluated by the IDC MarketScape.

According to the IDC MarketScape, "buyers are no longer satisfied with dashboards full of alerts and a monthly report. They are asking harder questions about analyst quality, SLA reliability under real stress, and whether GenAI investment inside the security operations center (SOC) is translating into better outcomes or simply faster-looking ones."

To help organizations build business-led resilience, Deloitte goes beyond traditional SOC services by aligning security objectives with broader business operations for enterprises. Deloitte professionals work alongside security leaders to demonstrate how cybersecurity is a business enabler, so leaders can be confident their businesses are protected against evolving threats. This approach is supported by an AI-enabled agentic SOC that helps to reduce false positives and helps accelerate response times, across a scalable and globally standardized architecture.

"As client needs move beyond fundamental security protections, security leaders increasingly expect their managed security collaborators to deliver specialized knowledge, outcome-driven AI innovation, and true strategic collaboration," says Ayan Chatterjee, Deloitte Global Cyber leader. "We believe Deloitte's MXDR team is positioned to help meet these expectations with deep security knowledge, differentiated capabilities, AI-driven SOC capabilities, and a dedication to measurable client outcomes."

"Backed by our security specialists, Deloitte is integrating Agentic AI capabilities to enhance threat detection, accelerate alert triage, and support faster remediation across security operations," says Chris Richter, Deloitte Global Detect and Response Product leader. "Combined with Deloitte's global delivery capabilities and deep industry expertise, these innovations help organizations address sector-specific threats, help to meet evolving regulatory requirements, and strengthen cyber resilience."

According to the IDC MarketScape, Deloitte's key strengths include:

- Multidisciplinary integration and business-aligned security operations: Deloitte sees its ability to connect MXDR to business transformation, regulatory obligations, and enterprise resilience as a key differentiator. Adjacency to audit, risk, compliance, M&A, and industry advisory practices enables framing detection outcomes in business impact terms. This integration is valued by customers undergoing digital transformation (DX) or regulatory alignment, where MXDR must align with strategic objectives. Coordinated delivery across identity modernization, crisis management, and vulnerability management reduces fragmentation if these capabilities are delivered by disparate teams.

- Measurable AI-driven impact with audited quality assurance: Deloitte's AI deployment delivers quantifiable productivity improvements that customers recognize as material value. Transparency around AI efficacy measurement includes measures such as tracking false positive rates, alert processing time, and analyst time savings. These measures provide confidence in their AI-augmented decisions. Deloitte reviews 20–30% of AI-processed alerts to validate accuracy and maintain feedback loops for retraining models. This approach addresses automation concerns and reinforces trust in AI-assisted workflows.

- Vendor-agnostic architecture with technology partnership ecosystem: Deloitte's platform-agnostic architecture supports broad SIEM, EDR, XDR, and analytics platforms without vendor lock-in.

- Global delivery with localized regulatory and industry expertise: Deloitte's combination of centralized Cybersphere Centers and distributed satellites delivers consistent SOC quality while accommodating country-specific regulatory requirements, data residency, and language needs. Customers in highly regulated sectors or multiple geographies value Deloitte's ability to align MXDR with sector-specific compliance frameworks and regional reporting. Industry depth in financial services, energy, healthcare, manufacturing, and government provides contextual awareness of sector threats, informing detection tuning and response.

Discover how Deloitte's MXDR services can help strengthen your cyber resilience, accelerate threat detection, and enhance your organization's security operations by visiting the Deloitte Global page for Managed Extended Detection & Response.

For more information about Deloitte Analyst Relations, please visit our Analyst Relations page.

About IDC MarketScape

IDC MarketScape vendor assessment model is designed to provide an overview of the competitive fitness of technology and service suppliers in a given market. The research utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each supplier's position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of technology suppliers can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective suppliers.

About Deloitte

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited (DTTL), its global network of member firms, and their related entities (collectively, the "Deloitte organization"). DTTL (also referred to as "Deloitte Global") and each of its member firms and related entities are legally separate and independent entities, which cannot obligate or bind each other in respect of third parties. DTTL and each DTTL member firm and related entity is liable only for its own acts and omissions, and not those of each other. DTTL does not provide services to clients. Please see www.deloitte.com/about to learn more.

Deloitte provides leading professional services to nearly 90% of the Fortune Global 500® and thousands of private companies. Our people deliver measurable and lasting results that help reinforce public trust in capital markets and enable clients to transform and thrive. Building on its 180+-year history, Deloitte spans more than 150 countries and territories. Learn how Deloitte's over 470,000 people worldwide work together every day to make an impact that matters at www.deloitte.com.

SOURCE Deloitte Global

Share this article

CovationBio's Xatryx® Mass Production On Spec, to Debut First Non‑Food Bio‑Based Athletic Insole at NW Materials Show in the U.S.

QIDONG, China, Sept. 2, 2026 /PRNewswire/ -- Covation Biomaterials LLC ("CovationBio"), a leading innovator in bio‑based materials, announces a successful production of its first series of commercial on spec batches of Xatryx.T bioTHF and Xatryx® bioPTMEG. Concurrently, the company, in collaboration with globally renowned insole brand INSITE®, will unveil the world's first athletic insole featuring Xatryx® bioPTMEG, a non‑food bio‑based material, at the NW Materials Show in Portland, Oregon. This marks a successful application development milestone, showcasing Xatryx® bioPTMEG's application from a raw material to a bio‑based footwear building block.

Xatryx® Qidong Plant Mass Production On Spec

Following the mechanical completion of its inaugural 50,000 ton commercial plant for its C4 platform technology in April 2026, CovationBio has rapidly advanced to successful production. In August 2026, the Qidong plant officially initiated the production of its first commercial batches, including Xatryx.T bioTHF as well as Xatryx® bioPTMEG series products in molecular weights of 2000, 1800, and 1000. Under rigorous internal quality control testing, all produced grades adhere to industry expected quality specifications.

Mr. You Feifeng, Chairman of CovationBio, commented, "From mechanical completion to the first commercial batches being on spec, the CovationBio team completed the entire process of equipment commissioning, process optimization, and scale‑up in just four months. The initial on‑spec status of all three molecular weight grades demonstrates the maturity and stability of our proprietary process technology. We are actively collaborating with downstream customers for trial sampling and collecting feedback, which will further validate the performance of our products in end‑use applications and their drop-in adaptability to existing application processes."

As a sustainable alternative to fossil‑based PTMEG, Xatryx® bioPTMEG can directly replace fossil‑based PTMEG, delivering outstanding product performance in downstream applications such as spandex, polyurethanes, and thermoplastic elastomers while significantly reducing reliance on non‑renewable materials.

Key sustainability advantages of the Xatryx® product include:

- Significantly lower greenhouse gas emissions from manufacturing compared to fossil‑based counterparts;

- Bio‑based content derived from annually renewable non‑food biomass (e.g., agricultural by‑products such as corncobs), avoiding competition with food supply;

- Reduced dependence on non‑renewable fossil fuels;

- Drop‑in solution for downstream customers, requiring no major process adjustments when switching to bio‑based materials.

INSITE ® and CovationBio® Collaborate to Deliver the First Partially Bio‑Based Athletic Insole made with Xatryx®

Alongside the production milestone, CovationBio is actively collaborating with the value chain to develop various downstream applications of Xatryx®. On September 2–3, 2026, at the NW Materials Show in Portland, CovationBio will co‑host the "Next‑Generation Bio‑Based Footwear Materials Application Forum" with INSITE®, a globally recognized insole brand, and officially introduce the world's first partially non‑food bio‑based athletic insole with Xatryx®.

This innovative insole product uses Xatryx® bioPTMEG as its core raw material, extending non‑food bio‑based materials from industrial feedstock to everyday athletic footwear. INSITE®, with its deep expertise in footwear biomechanics and podiatric design, joins forces with CovationBio in this cross‑industry collaboration, setting a new benchmark for sustainable materials in the insole industry.

Dr. Zhao Mosha, Global Marketing Director of CovationBio's C4 Platform, stated, "From the on‑spec mass‑production of Xatryx® at Qidong plant to the end‑product launch at the Portland footwear show, together with INSITE® we have achieved the leap from 'raw materials to end use' within just a few weeks. This is not only a technological milestone for both companies, but also a great example that with the drop-in capability of Xatryx® to replace fossil-based incumbent and the whole value chain innovative collaboration, the non‑food bio‑based material industry can move from concept to reality very efficiently. We look forward to joining hands with INSITE® and value‑chain partners of more applications to drive the sustainable transformation of the materials industry."

The NW Materials Show is one of the most influential professional exhibitions in the global footwear materials and functional fabrics sector. At the event, the CovationBio team will explain how Xatryx® empowers the footwear material supply chain and how it will work with global value‑chain partners to advance sustainable development strategies.

About CovationBio®

Covation Biomaterials LLC (CovationBio®) was established in 2022 and is headquartered in Newark, Delaware. The company possesses advanced and innovative technologies in the bio‑based materials field, focusing on offering a portfolio of high‑performance and sustainable solutions. Building on DuPont's pioneering scientific innovation legacy, CovationBio provides innovative solutions for industries in apparel, footwear, and carpet. Through its brands which include Xatryx® and Sorona®, CovationBio delivers essential materials that help create bio‑based products within reach for every customer.

CovationBio®, Xatryx® and Sorona® are trademarks of Covation Biomaterials or its affiliates.

Disclaimer: The above statements regarding greenhouse gas emissions assessment and product performance are based on internal testing results conducted by Covation Biomaterials LLC using representative methods. Actual results may vary depending on specific application scenarios and conditions of use.

Share this article